Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0137 Transporter Info
Gene Name	SLC20A2
Transporter Name	Sodium-dependent phosphate transporter 2
Gene ID	6575
UniProt ID	Q08357

Post-Translational Modification of This DT
Overview of SLC20A2 Modification Sites with Functional and Structural Information
Sequence	M A M D E Y L W M V I L G F I I A F I L A F S V G A N D V A N S F G T A V G S G V V T L R Q A C I L A S I F E T T G S V L L G A K V G E T I R K G I I D V N L Y N E T V E T L M A G E V S A M V G S A V W Q L I A S F L R L P I S G T H C I V G S T I G F S L V A I G T K G V Q W M E L V K I V A S W F I S P L L S G F M S G L L F V L I R I F I L K K E D P V P N G L R A L P V F Y A A T I A I N V F S I M Y T G A P V L G L V L P M W A I A L I S F G V A L L F A F F V W L F V C P W M R R K I T G K L Q K E G A L S R V S D E S L S K V Q E A E S P V F K E L P G A K A N D D S T I P L T G A A G E T L G T S E G T S A G S H P R A A Y G R A L S M T H G S V K S P I S N G T F G F D G H T R S D G H V Y H T V H K D S G L Y K D L L H K I H I D R G P E E K P A Q E S N Y R L L R R N N S Y T C Y T A A I C G L P V H A T F R A A D S S A P E D S E K L V G D T V S Y S K K R L R Y D S Y S S Y C N A V A E A E I E A E E G G V E M K L A S E L A D P D Q P R E D P A E E E K E E K D A P E V H L L F H F L Q V L T A C F G S F A H G G N D V S N A I G P L V A L W L I Y K Q G G V T Q E A A T P V W L L F Y G G V G I C T G L W V W G R R V I Q T M G K D L T P I T P S S G F T I E L A S A F T V V I A S N I G L P V S T T H C K V G S V V A V G W I R S R K A V D W R L F R N I F V A W F V T V P V A G L F S A A V M A L L M Y G I L P Y V
PTM type	X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC20A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	81
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC20A2 Asparagine 81 has the potential to affect its expression or activity.
Phosphorylation
Serine	23 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC20A2			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	106
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 106 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC20A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	253
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 253 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC20A2			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	256
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 256 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC20A2			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	259
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 259 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC20A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	261
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 261 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC20A2			[5] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	268
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 268 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC20A2			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	283
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 283 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC20A2			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	305
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 305 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC20A2			[5] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	316
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 316 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC20A2			[5] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	321
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 321 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC20A2			[5] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	324
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 324 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC20A2			[5] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	327
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 327 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC20A2			[9] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	351
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 351 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC20A2			[12] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	375
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 375 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC20A2			[5] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	385
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 385 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC20A2			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	413
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 413 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC20A2			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	422
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 422 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SLC20A2			[7] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	424
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 424 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SLC20A2			[16] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	432
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 432 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SLC20A2			[16] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	434
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 434 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SLC20A2			[16] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	435
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 435 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SLC20A2			[7] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	458
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 458 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SLC20A2			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	637
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Serine 637 has the potential to affect its expression or activity.
Threonine	10 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC20A2			[15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	69
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Threonine 69 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC20A2			[20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	243
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Threonine 243 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC20A2			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	284
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Threonine 284 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC20A2			[5] , [11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	318
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Threonine 318 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC20A2			[12] , [16]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	330
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Threonine 330 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC20A2			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	337
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Threonine 337 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC20A2			[21] , [22]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	346
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Threonine 346 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC20A2			[8] , [11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	387
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Threonine 387 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC20A2			[11] , [13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	390
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Threonine 390 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC20A2			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	420
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Threonine 420 has the potential to affect its expression or activity.
Tyrosine	10 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC20A2			[21] , [22]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	344
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Tyrosine 344 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC20A2			[12] , [22]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	354
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Tyrosine 354 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC20A2			[12] , [23]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	377
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Tyrosine 377 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC20A2			[8] , [11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	386
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Tyrosine 386 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC20A2			[8] , [11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	389
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Tyrosine 389 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC20A2			[7] , [24]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	423
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Tyrosine 423 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC20A2			[16] , [18]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	430
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Tyrosine 430 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC20A2			[16] , [18]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	433
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Tyrosine 433 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC20A2			[16] , [18]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	436
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Tyrosine 436 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC20A2			[2]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	646
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC20A2 Tyrosine 646 has the potential to affect its expression or activity.
Ubiquitination
Lysine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC20A2			[25]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	262
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC20A2 Lysine 262 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC20A2			[26]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	272
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC20A2 Lysine 272 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC20A2			[25] , [26]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	278
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC20A2 Lysine 278 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC20A2			[25] , [26]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	360
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC20A2 Lysine 360 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC20A2			[25]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	370
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC20A2 Lysine 370 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC20A2			[25]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	415
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC20A2 Lysine 415 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC20A2			[27]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	425
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC20A2 Lysine 425 has the potential to affect its expression or activity.

References
1	Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptor. J Virol. 2001 Jun;75(12):5584-92.
2	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
4	Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer. PLoS One. 2018 Oct 2;13(10):e0204658.
5	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
6	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
7	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
8	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
9	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
10	Quantitative Phosphoproteome Analysis of Clostridioides difficile Toxin B Treated Human Epithelial Cells. Front Microbiol. 2018 Dec 17;9:3083.
11	Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun. 2018 Sep 11;9(1):3679.
12	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
13	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
14	Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling. Mol Cell Proteomics. 2016 Aug;15(8):2671-85.
15	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
16	Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
17	Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle. J Biol Chem. 2017 Sep 1;292(35):14311-14324.
18	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
19	Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
20	Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
21	Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters. J Proteome Res. 2017 Feb 3;16(2):1077-1086.
22	Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis. Anal Chem. 2017 Sep 5;89(17):9307-9314.
23	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
24	Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis. Cell Metab. 2019 Jan 8;29(1):141-155.e9.
25	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
26	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
27	New findings on essential amino acids. Cesk Fysiol. 1990;39(1):13-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence